Rick Flemming, Founding Director at Aspire Scientific, reviews the key points he took from day 1 of the 2018 European meeting of the International Society for Medical Publication Professionals (ISMPP), 23-24 January 2018; London, UK.

Recorded 7 February 2018 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

ABSTRACT:

The overarching theme of the 2018 European meeting of ISMPP was ‘Advancing medical publications in a complex evidence ecosystem’. The meeting began with a review of the medical publications highlights of 2017, provided by Jackie Marchington (Caudex). These included the formation of Open Pharma, a multi-stakeholder initiative that aims to help drive fast and transparent publication of industry-funded medical research.

The opening panel session, moderated by Russell Traynor (Envision Pharma), focused on the challenges involved in ensuring compliant, efficient and effective disclosure and publication of industry-generated clinical trial data. Potential solutions to these challenges were discussed by a panel of industry experts, with delegates hearing that we are already transitioning toward a model of ‘integrative data disclosure planning’ involving increasingly close collaboration between internal teams.

The day’s second panel discussion, moderated by Richard Smith (Open Pharma), asked if it was ‘Time to embrace change in medical publishing?’. Delegates were informed of the intricacies, challenges and recent advances around open-access publication of industry-sponsored research. The potential of non-traditional publication platforms to hasten data dissemination was also discussed.

The impact of artificial intelligence (AI) in medical publishing, and medicine in general, was considered in a debate moderated by Martin Delahunty (Inspiring STEM Consulting) entitled ‘Will we be replaced by robots’? Regardless of the answer to that question, AI is already playing an important role in these areas, and this will only increase in future.

The first day of the meeting concluded with updates on ISMPP itself, including the society’s intention to continue growing its membership through education and collaboration.

Written by Rick Flemming, Founding Director at Aspire Scientific

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts, like this one, for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new topics and speakers.

Full details of this MedComms Networking event are at http://medcommsnetworking.com/event_070218.html

Rick’s presentation (PDF format) is at http://medcommsnetworking.com/presentations/flemming_070218.pdf

Rick’s Linkedin page is at https://www.linkedin.com/in/rick-flemming-4199a86/

More about Aspire Scientific can be found at http://www.aspire-scientific.com

The Publication Plan provides an educational news service for professionals involved in the development of medical publications at https://thepublicationplan.com

Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor

Editorial support by Penny Gray, Freelance Medical Writer

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]